Pluristem therapeutics inc (PSTI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period

-7,507

-6,370

-7,139

-7,760

-10,078

-8,683

-8,786

-8,981

-1,531

-8,229

-7,385

-7,016

-7,864

-6,610

-6,324

-6,205

-7,203

-3,962

-5,876

-5,295

-7,226

-6,245

-5,911

-6,196

-9,276

-6,705

-4,755

-6,990

-5,680

-4,490

-3,995

-4,135

-10,652

4,486

-4,493

-3,725

-2,613

-2,821

-1,689

Depreciation

363

385

468

481

480

498

503

506

489

508

515

531

536

552

558

560

559

534

497

576

496

504

498

486

479

476

461

441

316

146

130

123

311

-96

97

88

80

74

70

Loss from sale of property and equipment, net

-

-

-

-

-

-

-

-

-

-

-

-77

1

0

4

-85

2

-2

3

-20

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-8

Linkage differences and interest on long-term restricted lease deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-2

-1

Accretion of discount, amortization of premium and changes in accrued interest of marketable securities

-

-

-

-

-

-

-

0

-1

-1

13

203

-14

-121

-33

-155

-105

10

136

-20

88

101

44

1,015

-198

-94

559

-15

116

10

43

191

-173

-4

4

-

-

-

-

Gain from sale of investments of available-for-sale marketable securities

-

-

-

-

-

-

-

0

7,512

0

928

326

16

16

4

-116

-323

3

17

0

-487

214

-17

835

-272

22

142

47

2

-8

-15

3

0

0

0

-

-

-

-

Other-than-temporary loss of available-for-sale marketable securities

-

-

-

-

-

-

-

0

0

0

850

767

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation to employees, directors and non-employee consultants

371

767

864

1,197

1,753

869

1,327

1,653

1,787

1,605

1,503

1,080

1,675

422

485

706

796

663

908

1,140

1,158

694

1,060

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation to employees, directors and non-employees consultants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,176

-

-

-

1,063

-

3,531

-1,039

1,041

989

872

1,002

462

Stock compensation to investor relations consultants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

273

-

1

-1

1

0

77

42

36

Decrease (increase) in accounts receivable from the IIA

-

-17

-108

-

-

45

-21

-538

424

147

-1,011

718

31

-172

-1,769

2,048

30

-269

-1,272

1,487

46

-293

-1,812

1,980

-267

-1,873

2,150

-445

-293

62

746

-1,356

1,584

-74

76

-391

52

108

-425

Increase in other current assets and other long-term assets

-1,198

236

483

667

-1,515

719

526

340

-9

-442

170

128

498

173

-68

-357

-6

-169

-863

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in other accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

457

517

-333

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

174

-

171

-123

7

-

-129

94

483

-127

-141

-20

20

101

157

-24

39

Decrease in trade payables

-91

-1,039

661

-643

821

-79

-962

1,225

73

268

-354

223

-1,084

549

-389

811

65

373

-1,326

270

-64

217

-989

672

97

241

247

1,126

-1,970

1,191

988

-799

375

86

-87

-61

262

253

1

Decrease in other accounts payable, accrued expenses, other current liabilities and other long-term liabilities

237

182

-1,648

198

134

-164

-82

-656

1,835

711

-290

-1,062

1,788

-544

-44

171

3

1,216

-165

318

-850

-408

-9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in operating lease right-of-use asset and liability, net and effect of exchange rate differences

-

-76

-27

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in other accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

160

-

-

-78

30

-

51

-204

205

219

122

1

33

Decrease in deferred revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-2,752

-95

-94

-95

-95

-95

-94

-95

284

-474

-95

-195

-194

-195

-101

4,380

-4,841

4,846

-

-

-

-

Decrease in advance payment from United Therapeutics Corporation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-70

-23

-31

-19

-75

-29

-14

-36

-59

-37

-174

-32

-360

-617

67

1,507

-1,998

2,000

-

-

-

-

Decrease in interest receivable on short-term deposits

111

-77

38

-236

228

-67

7

-191

291

73

-45

24

0

-2

2

-8

-6

74

-35

-16

-33

5

9

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-19

4

Linkage differences and interest on short and long-term deposits and restricted bank deposits

-

-3

-4

-

-

-

-

1

2

-1

3

8

-21

2

-3

10

-37

0

24

59

-70

28

37

39

-28

169

-168

128

-56

-65

-37

300

-264

-55

55

-

-

-

-

Accrued severance pay, net

-6

-5

-3

-23

7

-10

2

71

-12

89

-3

-5

8

-11

0

2

30

4

2

-1

3

-22

-41

-49

105

-42

35

-30

16

-6

9

-25

29

1

-1

31

32

-15

10

Net cash used by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,589

-3,621

-3,768

-

-6,562

-5,570

-3,456

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used by operating activities

-6,505

-6,301

-7,241

-6,673

-6,007

-8,263

-8,510

-5,786

-5,576

-4,828

-5,190

-6,390

-5,522

-5,776

-3,923

-

-

-

-

-

-

-

-

-

-

-

-5,095

-

-

-

-3,522

-

-2,345

-3,460

3,461

-2,159

-1,377

-1,531

-688

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

29

74

54

22

24

16

177

123

34

37

148

18

87

128

145

215

64

365

1,106

193

86

281

271

137

267

707

462

1,062

-91

1,360

1,978

167

1,312

-178

179

290

112

134

426

Repayment of long-term deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7

-2

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from short-term deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

498

400

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

22

2

0

6

-1

26

0

3

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

28

Proceeds from short-term deposits

-704

-5,984

-4,802

18,493

-6,799

-5,308

-7,801

-5,600

10,607

13,756

-4,042

-6,164

12,333

-6,708

-1,834

-2,675

-5,270

866

7,928

-3,550

-1,439

-6,295

-4,777

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of (investment in) long-term deposits and restricted bank deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-1

1

-3

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment in short-term deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,132

-

-

-

0

-

-21,596

31,568

-31,599

-

-

-

-

Repayment (investment) in long-term deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-

-

-

-300

-

524

-688

690

-

-

-

-

Repayment of long-term restricted deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

112

-

-

6

3

-

5

-3

4

0

0

11

2

Proceeds from sale of available-for-sale marketable securities

-

-

-

-

-

-

-

0

12,871

0

9,010

905

809

1,081

2,732

4,136

1,809

537

517

756

7,470

2,372

37

2,238

912

1,093

1,870

1,169

220

146

313

-

-

-

-

-

-

-

-

Proceeds from redemption of available-for-sale marketable securities

-

-

-

-

-

-

-

0

0

0

9

8

122

225

55

28

415

422

229

194

139

237

64

-

-

-

-

-

-

-

-

-636

749

0

0

-

-

-

-

Investment in available-for-sale marketable securities

-

-

-

-

-

-

-

0

0

0

1,146

1,315

730

876

686

261

1,411

1,967

576

1,375

1,015

2,421

92

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from redemption of available-for-sale marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

394

-

-

304

0

-

-

-

-

-

-

-

-

Investment in available-for-sale marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,861

-

-

956

1,248

-

6,561

-511

516

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,044

-2,236

-8,859

-

7,954

6,204

4,516

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

674

5,912

4,748

-18,515

6,775

5,286

7,624

5,477

2,230

-13,793

11,767

5,766

-12,217

7,012

3,794

-

-

-

-

-

-

-

-

-

-

-

4,182

-

-

-

-2,610

-

-29,239

32,943

-32,980

-291

-112

363

4

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds related to issuance of common stock, net of issuance costs

5,395

3,986

1,981

19,757

1,758

1,479

473

2,573

1,386

13,646

1,026

0

15,718

0

0

0

0

0

790

15,800

586

528

0

-

-

-

0

0

0

0

34,106

0

0

0

0

0

38,385

4,763

252

Exercise of warrants and options

-

-

-

0

0

-99

107

34

3

1,141

24

0

6

0

4

0

1

0

16

36

5

137

109

-

-

-

509

337

23

450

1,388

235

396

-322

323

-

-

-

-

Proceeds with respect to Israel-United States Binational Industrial Research and Development Foundation liability

-

-

-

0

0

99

8

0

0

88

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

806

-

591

665

109

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of long-term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

24

Net cash provided by financing activities

5,395

3,986

1,981

19,757

1,758

1,479

588

2,607

1,389

14,875

1,050

69

15,724

0

4

-

-

-

-

-

-

-

-

-

-

-

509

-

-

-

35,494

-

396

-322

323

413

41,616

4,780

228

Increase in cash and cash equivalents and restricted cash

-436

3,597

-512

-5,431

2,526

-1,498

-298

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-2,015

1,236

-125

819

456

-5,857

-11,821

13,682

1,983

1,299

1,169

855

-988

-3,977

-404

-18,814

4,273

-15,203

29,362

-2,216

-31,187

29,159

-29,196

-2,037

40,127

3,612

-456

Increase (decrease) in cash and cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

7,627

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(a) Supplemental disclosure of cash flow activities:
Taxes paid due to non-deductible expenses

3

2

3

3

2

3

2

19

2

3

3

8

4

8

8

16

7

35

8

7

30

-13

30

5

8

4

31

3

12

0

3

2

11

-7

8

2

2

2

5

(b) Supplemental disclosure of non-cash activities:
Purchase of property and equipment on credit

44

6

2

32

-2

19

5

112

43

-13

29

64

-12

-62

98

-74

68

-33

165

603

-63

-116

188

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash and cash equivalents

-538

3,585

3,715

-

2,739

-1,637

8,433

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash included in Restricted cash and short-term bank deposits

102

12

959

-

-213

139

777

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows

-436

3,597

4,674

-

2,526

-1,498

9,210

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share consideration to contractor

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-26

65

263

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment on credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

668

-

-

510

78

-

99

-108

109

-45

95

0

73

Receivables on account of shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock based compensation to contractor

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

1,400

-

-

-

-

-

-

-

-